PHILADELPHIA, Dec. 30, 2024 (GLOBE NEWSWIRE) --
Kaskela Law LLC announces that it is investigating Pactiv Evergreen Inc. (NASDAQ: PTVE) (“Pactiv”) on behalf of the company’s current shareholders.
Click here for additional information: https://kaskelalaw.com/case/pactiv-evergreen/
On December 9, 2024, Pactiv announced that it had agreed to be acquired by Novolex at a price of $18.00 per share in cash. Following the closing of the proposed transaction, Pactiv’s current stockholders will be cashed out of their investment position and the company’s shares will no longer be publicly traded.
The investigation seeks to determine whether Pactiv’s officers and/or directors violated the securities laws in agreeing to sell the company at $18.00 per share, and whether $18.00 per share represents sufficient monetary consideration for Pactiv’s investors.
Pactiv shareholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) at (484) 229 – 0750 to receive additional information about this investigation and their legal rights and options.
Alternatively, investors may submit their information to the firm by clicking on the following link (or if necessary, by copying and pasting the link into your browser):
https://kaskelalaw.com/case/pactiv-evergreen/
Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance, and merger & acquisition litigation on a contingent basis. For additional information about Kaskela Law LLC please visit www.kaskelalaw.com.
CONTACT:
KASKELA LAW LLC
D. Seamus Kaskela, Esq.
Adrienne Bell, Esq.
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(888) 715 – 1740
(484) 229 – 0750
www.kaskelalaw.com
This notice may constitute attorney advertising in certain jurisdictions.
